Update 12/9/11: I wrote this story back in March, and it continues to make me nervous. Alone, it's nothing. Just another example of industry being excluded in policy shifts. Taken in a larger context, however it demonstrates how vulnerable reputation of the medtech industry is right now, and how the loss of reputation can influence real world concerns. We’ve seen that the result of noninvolvement can be disappointing, as with IOM choosing not to have industry involved in its 510(k) report, or disastrous, as with industry choosing not to be involved with healthcare reform.
Are you as worried about this as I am?